T2 Biosystems, Inc.
T2 Biosystems, Inc., a pioneering company in the field of molecular diagnostics, is headquartered in the United States. Founded in 2006, T2 Biosystems has established itself as a leader in the development of innovative diagnostic solutions, particularly in the areas of sepsis and infectious diseases. The company’s flagship products, including the T2Dx® Instrument and T2Candida® Panel, utilise advanced technology to deliver rapid and accurate results, setting them apart in the competitive diagnostics market. With a strong focus on improving patient outcomes, T2 Biosystems has achieved significant milestones, including FDA clearances and partnerships with major healthcare institutions. Their commitment to transforming the diagnostic landscape positions them as a key player in the industry, dedicated to enhancing clinical decision-making and patient care.
DitchCarbon Score
How does T2 Biosystems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
T2 Biosystems, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
T2 Biosystems, Inc.'s reported carbon emissions
T2 Biosystems, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that T2 Biosystems may not yet have established a comprehensive framework for addressing its carbon footprint or climate impact. In the context of the biotechnology industry, many companies are increasingly focusing on sustainability and climate commitments. However, without specific initiatives or targets, T2 Biosystems appears to be at an early stage in its climate strategy. As the industry evolves, it may be beneficial for the company to consider setting measurable goals and participating in recognised climate initiatives to enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
T2 Biosystems, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
